<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_TU-Eindhoven_Modeling_PPI skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:TU-Eindhoven/Modeling/PPI</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE> iGEM TU Eindhoven </TITLE></P><DIV class="Website_Top"><DIV class="The_Menu"><UL class="Menu_List"><LI><A class="active_1" href="https://2016.igem.org/Team:TU-Eindhoven">Home</A></LI><LI class="hover"><A class="active_2" href="https://2016.igem.org/Team:TU-Eindhoven/Team">Team</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Team/Members">Members</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Advisors">Advisors</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Collaborations">Collaborations</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Sponsors">Sponsors</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Attributions">Attributions</A></LI></UL><LI class="hover"><A href="https://2016.igem.org/Team:TU-Eindhoven/Description" class="active_3">Project</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Description">Description</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Project_Background">Background</A></LI><LI class="hover2"><A style="cursor:default">Scaffold Design</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Scaffold_Design">Heterodimer</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Scaffold_Design_Tetramer">Tetramer</A></LI><LI class="hover2"><A style="cursor:default">Experiments</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Read-out">Heterodimer</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Read-out/Tetramer">Tetramer</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Timeline">Timeline</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Protocols">Protocols</A></LI><LI class="hover"><A href="https://2016.igem.org/Team:TU-Eindhoven/Modeling/Rosetta" class="active_4">Modeling</A></LI><LI class="hover2"><A style="cursor:default">Rosetta</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Modeling/Rosetta">Model</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Modeling/Rosetta_Results">Results</A></LI><LI class="hover2"><A style="cursor:default">PPI</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Modeling/PPI">Model</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Modeling/PPI_Results">Results</A></LI><LI class="hover"><A class="active_6" href="https://2016.igem.org/Team:TU-Eindhoven/Results/Introduction">Results</A></LI><LI class="hover2"><A style="cursor:default">Heterodimer</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Results/Introduction">Introduction</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Results/Functionality">Functionality</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Results/Orthogonality">Orthogonality</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Results/Conclusion">Conclusion</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Results/Tetramer">Tetramer </A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Results/NanoBit">NanoBiT curve</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Proof">Proof of Concept </A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Interlab">Interlab Study </A></LI><LI class="hover2"><A style="cursor:default">Biobricks</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Parts">Parts</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Basic_Part">Basic Part</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Achievements"> Achievements</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Future">Future</A></LI><LI class="hover"><A class="active_5" href="https://2016.igem.org/Team:TU-Eindhoven/Human_Practices">Policy &amp; Practices</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/HP/Silver">Outreach</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/HP/Gold">Safe By Design</A></LI><LI class="hover2"><A style="cursor:default">Applications</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/T-Cell">T-Cell Therapy</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Alzheimer">Transport Bacteria</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Industrial">Co-Enzym Regen.</A></LI><LI class="hover2"><A style="cursor:default">Safety</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Safety/Lab">Lab</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Safety/Project">Project</A></LI><DIV class="email"><A title="mailto:igem@tue.nl" id="emaillink" href="mailto:igem@tue.nl"><SPAN class="size">✉</SPAN></A></DIV></DIV></DIV><DIV class="Website"><DIV class="Header_Panel"><DIV class="Panel"><DIV class="Panel_Title">
				PPI Model
			</DIV><DIV class="Panel_Description">
			Protein-Protein-Interaction model			</DIV></DIV></DIV><DIV class="wrap"><DIV class="Sub_Menu"><UL class="Side_Menu"><LI class="Sub_Sub_Menu"><A>Rosetta</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Modeling/Rosetta">Model</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Modeling/Rosetta_Results">Results</A></LI></UL><LI class="Sub_Sub_Menu tap"><A>PPI Model</A></LI><LI><A class="active" href="https://2016.igem.org/Team:TU-Eindhoven/Modeling/PPI">Model</A></LI><LI><A href="https://2016.igem.org/Team:TU-Eindhoven/Modeling/PPI_Results">Results</A></LI></DIV><DIV class="The_Content"><DIV class="Column"><P>
				In order to determine the properties of our designed protein pairs that cannot be directly measured, like the binding affinities/dissociation constants and cooperativity of our designed orthogonal pairs, we have developed a model based on mass-action and Michealis-Menten kinetics.
			</P><P>
				Our readouts will be done with our system in a quasi-steady state, so that is what our model will also be based on: It will be divided in 2 separate segments, the first will determine the quasi-steady state concentrations of all the proteins and protein-complexes in our system, the second will simulate the total activity based on the combined concentrations of the active complexes (both scaffold and non-scaffold mediated) in our system.
			</P></DIV><DIV class="P_Header"> Finding the equilibrium of our system</DIV><DIV class="Content_Row"><DIV class="Column_50"><P>
					In order to find the quasi-steady state approximation of the system we must analyze the enter cascade of complex-formations starting from the base proteins/ligands (see figure 1). The steady state assumption allows us to determine the mass-action kinetics between the proteins with dissociation constants. Dissociation constants present in our system are between T14-3-3 and fusicoccin (K<SUB>D,Fc</SUB>)and between the T14-3-3-FC complex and the CT52s (K<SUB>D,C1</SUB> and K<SUB>D,C2</SUB>), The Dissociation constants must be separated since they are not identical and thus do not have the same binding affinity to their respective T14-3-3 monomers, and the Dissociation constant of the non scaffold mediated active complex (K<SUB>D,NoB</SUB>). 				Besides Dissociation constants, a cooperativity parameter σ is introduced to simulate the stimulating (σ &gt; 1) or inhibitory (σ &lt; 1) effects of the first CT52 on the scaffold on the binding of the second CT52. 

				</P></DIV><DIV class="Column_50"><DIV id="Equilibrium_Caption" class="Caption">Figure 1: A schematic representation of the complex-forming cascade of our heterodimeric T14-3-3 CT52 system.</DIV></DIV></DIV><DIV class="P_Header">Formation of active complexes</DIV><DIV class="Column"><P>
				From figure 1 the mass-action equations can be derived. For the ease of notation the T14-3-3 scaffold will be represented as B, fusicoccin as F, and CT52 by C, followed by a number (1 or 2) if necessary. The following equations can be derived:
			</P></DIV><DIV id="Height_200" class="Content_Row"><DIV class="Column_30"><P>
					And non scaffold mediated:
				</P></DIV></DIV><DIV class="Column"><P>
				Using the law of mass conservation we can setup equations for the total concentrations of the separate proteins and ligands in our system, which we can control during our assay:
			</P></DIV><DIR class="Column"><P>
				By substituting equations 1-13 in equations 14-17, we get (ridiculously lengthy) equations describing the free concentrations of the system:
			</P></DIR><DIV class="Column"><P>
				In order to solve equations 18 – 21 which contain multiple unknown variables, fixed point iteration is used using the initial conditions we use during our assays. Once equations 18-21 do not significantly change anymore we can assume the system is in a steady state and by using the results of the fixed point iteration we can calculate the concentrations of the complex species using equations 1-13, and finish the first segment of our model.
			</P></DIV><DIV class="P_Header">Activity</DIV><DIV class="Content_Row"><DIV class="Column_50"><P>
					In order to determine the activity of the active complexes, we first state that concentration of enzyme [E] is the sum concentrations of scaffold (BFFCC) and non-scaffold (CC) mediated complexes. Next we use Michaelis-Menten kinetics to determine the initial concentration of the enzyme-substrate complex:
				</P></DIV></DIV><DIV class="Column"><P>
				Using this initial enzyme-substrate concentration and the catalytic rate (kcat) of the active enzyme, the initial reaction rate can be calculated. To convert this reaction rate (which is calculated in μM/s) into the activity which is measured in the assay and then calibrated using a substrate specific calibration curve, the following formula is used:
			</P></DIV><DIV class="Column"><P>
				With Mw the molecular weight of the fused C9-CT52 protein (the molecular weight of different variants of CT-52 are assumed to be the same), the resulting activity is expressed in U/mg.
			</P></DIV></DIV></DIV><DIV class="Footer"><A href="#" class="back-to-top"> back to top</A></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>